21st Annual PEGS Boston - The Essential Protein Engineering and Cell Therapy Summit

Topics

• Safety
  • Immunogenicity for Regulatory Success
  • PK/PD of Multi-Domain Proteins
  • Immunogenicity Prediction and Mitigation
• Engineering
  • Engineering Antibodies
  • Phage and Yeast Display of Antibodies and Recombinant Proteins
  • Engineering Bispecific Antibodies
• Oncology
  • Bispecific Antibodies to the Clinic for Oncology
  • Antibodies for Cancer Therapy
  • Antibody-Drug Conjugates
• Bioprocess
  • ADC Development and Manufacturing
  • Scaling Up and Down Strategies for Protein Production
• Expression
  • Optimizing Protein Expression
  • Difficult to Express Proteins
  • Higher Level Expression of Enzymes
• Therapeutics
  • Adoptive T Cell Therapy
  • Biologics for Autoimmune Diseases
  • Peptide Therapeutics
• Analytical
  • Biophysical Analysis of Biotherapeutics
  • Characterization of Biotherapeutics
  • Protein Aggregation and Stability in Biopharmaceuticals